Agilon Health Amends Credit Agreement, Extends Debt Maturity

Agilon Health ( (AGL) ) just unveiled an announcement.

On February 12, 2026, agilon health, inc., together with related entities, entered into a third amendment to its existing credit agreement that extends the maturity date of its term loans from February 18, 2026 to February 18, 2028 and revises key financial covenants. The amendment shifts certain covenant baskets to EBITDA-based measures, imposes a $50 million daily minimum cash requirement, restricts certain payments to periods after the company generates positive EBITDA for two consecutive trailing four-quarter periods, requires term-loan prepayments with any reduction in letters of credit, reduces revolving commitments from $100 million to $90 million, increases cash collateralization of letters of credit, and is supported by a new unsecured parent guaranty, collectively tightening liquidity discipline while providing extended debt maturity.

These changes are likely to strengthen the company’s capital structure by providing additional time before debt repayment while also imposing stricter liquidity and performance thresholds on management. For lenders and other stakeholders, the revised terms increase safeguards around cash, collateral, and leverage, suggesting a recalibration of risk and return expectations as agilon navigates future operating conditions under its value-based care model.

The most recent analyst rating on (AGL) stock is a Hold with a $0.73 price target. To see the full list of analyst forecasts on Agilon Health stock, see the AGL Stock Forecast page.

Spark’s Take on AGL Stock

According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.

The score is held down primarily by weak financial performance (shrinking revenue, negative margins, and negative operating cash flow) and ongoing loss-heavy guidance from the latest earnings call. Technicals provide a modest near-term uplift, but valuation is hard to justify with negative earnings, and corporate-event risk is elevated due to the NYSE delisting notice.

To see Spark’s full report on AGL stock, click here.

More about Agilon Health

Agilon health, inc. operates in the healthcare services industry, focusing on value-based care arrangements that align primary care physicians with Medicare Advantage and other health plan partners. Through affiliated entities, the company manages clinical and financial risk, aiming to improve outcomes and cost efficiency for seniors in key U.S. markets.

Average Trading Volume: 7,600,461

Technical Sentiment Signal: Sell

Current Market Cap: $186.8M

See more data about AGL stock on TipRanks’ Stock Analysis page.